Umbilical Cord-Derived Mesenchymal Stem Cells are Able to Use bFGF Treatment and Represent a Superb Tool for Immunosuppressive Clinical Applications

Mesenchymal stem cells (MSCs) have become a promising tool in cellular therapy for restoring immune system haemostasis; however, the success of clinical trials has been impaired by the lack of standardized manufacturing processes. This study aims to determine the suitability of source tissues and cu...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Lenka Tesarova, Klara Jaresova, Pavel Simara, Irena Koutna
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: MDPI AG 2020-07-01
Reeks:International Journal of Molecular Sciences
Onderwerpen:
mesenchymal stem cells
umbilical cord
advanced therapy medicinal product
immunosuppression
Online toegang:https://www.mdpi.com/1422-0067/21/15/5366
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items